Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
11/2008
11/20/2008US20080287346 Bioactive peptides
11/20/2008CA2723671A1 Tubulysine derivatives
11/20/2008CA2686997A1 Quaternary alkyl ammonium bacterial efflux pump inhibitors and therapeutic uses thereof
11/20/2008CA2686994A1 Polybasic bacterial efflux pump inhibitors and therapeutic uses thereof
11/19/2008EP1992637A1 1-Aminocyclopentane-1,3,4- tricarboxylic acids derivatives
11/19/2008EP1992353A1 Vasodilator
11/19/2008EP1992352A1 Agent for preventing arteriosclerosis, agent for suppressing vascular intimal thickening and agent for improving vascular endothelial function
11/18/2008US7452964 Compositions and methods of use of targeting peptides against placenta and adipose tissues
11/18/2008US7452875 Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
11/18/2008US7452862 Conformationally-controlled biologically active macrocyclic small molecules as motilin antagonists or ghrelin agonists
11/18/2008US7452683 Identifying enzyme modulators for treating neurodegenerative, autoimmune and tumor diseases
11/18/2008US7452679 Hybridization; phage display; spectroscopy
11/18/2008CA2331850C Method of preparing carboxylic acid derivatives and condensing agent comprising a quaternary ammonium salt
11/18/2008CA2124329C Compounds, compositions and methods for binding bio-affecting substances to surface membranes of bio-particles
11/13/2008WO2008083678A3 Pharmaceutically active compounds
11/13/2008WO2008068752A3 Formation of organic nanostructure array
11/13/2008WO2008027800A3 Method for enhancing the efficacy of antigen specific tumor immunotherapy
11/13/2008US20080281075 Asymmetric synthesis of peptides
11/13/2008US20080280834 Compounds and methods for inhibiting apoptosis
11/13/2008US20080280822 Nucleic acid and corresponding protein entitled 161P5C5 useful in treatment and detection of cancer
11/13/2008US20080280319 GSH adducts and uses thereof
11/13/2008US20080279873 Active immunization to generate antibodies to soluble a-beta
11/13/2008US20080279869 Method for reducing neuronal degeneration by administering cns-derived peptides or activated t cells
11/13/2008US20080279765 targeting the mannose-6-phosphate (M6P) receptor suitable for the non-invasive visualization
11/12/2008EP1990057A1 Beta-secretase substrates and uses thereof
11/12/2008EP1989324A1 Pcr hot start by magnesium sequestration
11/12/2008EP1989180A1 Modified amino acids
11/12/2008EP1478659B1 Biologically active peptides
11/12/2008EP1472278B1 Macrocyclic peptides active against the hepatitis c virus
11/12/2008EP1432729B1 Peyers's patch and/or m-cell targeting ligands
11/12/2008EP1395275B1 Beta-secretase substrate and uses thereof
11/12/2008EP1208238B1 Methods of immobilizing ligands on solid supports
11/12/2008CN101305281A KOKUMI-imparting agent
11/12/2008CN101305017A Bioactive peptides identified in enzymatic hydrolyzates of milk caseins and method of obtaining same
11/12/2008CN101302245A Melanin cortical hormone receptor tetrapeptide excitant, preparation and use thereof
11/12/2008CN100432097C Synthetic methods for nutame
11/11/2008US7449591 Diminishing concentration of metal complex from solution containing the complex by addition of an optionally fused and/or optionally substituted heterocyclic compound which is a solubility-enhancing compound that enhances solubility of complex in second solution
11/11/2008US7449546 Dissolving a predetermined quantity of reduced glutathione in an aqueous medium having a pH of between 5.0 and 8.0 to produce a reduced glutathione solution having a predetermined initial concentration; storing solutions of reduced glutathione without allowing oxidation of the glutathione to a disulfides
11/11/2008US7449544 Inhibiting cyclin dependent kinase 2/cyclin complexes
11/11/2008US7449493 N-[2-[[1-[[[(2,4-dimethylphenyl)methyl]amino]methyl]cyclohexyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide; monocyte chemoattractant proteins receptor antagonists or partial agonists/antagonists; antiinflammatory agent, autoimmune diseases; rheumatoid arthritis, multiple sclerosis, atherosclerosis
11/11/2008US7449479 Hepatitis C virus inhibitors
11/11/2008US7449447 Peptidomimetic NS3-serine protease inhibitors of hepatitis C virus
11/11/2008US7449446 Synergistic mixture; anticoagulants
11/11/2008US7449445 Conductive peptide nanofiber and method of manufacture of the same
11/06/2008WO2008132759A2 Industrially advantageous process for the production of lisinopril dihydrate
11/06/2008WO2008132153A1 Novel tetrahydrocarbazole derivatives as ligands of g-protein coupled receptors
11/06/2008WO2008106151A3 Co-crystals and pharmaceutical compositions comprising the same
11/06/2008WO2008088846A3 Substance p and analogs thereof as an immunogenic composition adjuvant
11/06/2008WO2008076824A3 Therapeutic and diagnostic peptides
11/06/2008WO2008073174A3 Antimicrobial therapy
11/06/2008WO2008070358A3 N-cyclopropyl-hydroxyproline-based tripeptidic hepatitis c serine protease inhibitors containing an isoindole, pyrrolopyridine, pyrrolopyrimidine or pyrrolopyrazine heterocycle in the side chain
11/06/2008WO2008048373A3 Compounds and methods for modulating protein degradation
11/06/2008US20080275216 Fluorous Capping Reagents and Methods for Peptide Purification
11/06/2008US20080275024 Amyloid precursor protein/gamma-secretase inhibitors; amides of aminobenzodiazepines: 2-(3,5-difluorophenyl)-N {[N-(1-methyl-2-oxo-5-phenyl((S)-3H-benzo[f]1,4-diazepin-3-yl))carbamoyl]cyclohexyl}acetamide
11/06/2008US20080275010 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
11/06/2008US20080274982 Peptide Substance Restoring Respiratory Organs Function
11/06/2008US20080274981 Compositions and methods for regulating apoptosis
11/06/2008US20080274978 Tryptophan rich mimics; antiinflammatory agents; drug screening for formyl peptide receptor like 1 (FPRL1) activity; arthritis, autoimmune disorders, Alzheimer's disease
11/06/2008US20080274977 Treating stroke and other diseases without inhibiting N-type calcium channels
11/06/2008US20080274171 Renin Inhibitors Nitroderivatives
11/06/2008CA2685428A1 Novel tetrahydrocarbazole derivatives as ligands of g-protein coupled receptors
11/05/2008EP1988098A1 Novel Tetrahydrocarbazole Derivatives as Ligands of G-protein Coupled Receptors
11/05/2008EP1696944A4 Branched peptide amphiphiles, related epitope compounds and self assembled structures thereof
11/05/2008EP1505945B1 Substituted cycloalkyl p1' hepatitis c virus inhibitors
11/05/2008EP0994724B1 Methods and compositions for impairing multiplication of hiv-1
11/05/2008EP0912601B2 Suppression of immune response via inhibition of cathepsin s
11/05/2008CN100430414C Tripeptides having a hydroxyproline ether of a substituted quinoline for the inhibition of NS3 (hepatitis C)
11/05/2008CN100430378C New piperidine derivative
11/04/2008US7446102 Antibacterial amide macrocycles IV
11/04/2008US7446094 Cylcic peptide containing oxazole/thiazole/imidazole fragment and aminoacidic fragment; antitumor agents
11/04/2008US7445905 Contacting cells with receptor and determining formation of complexes; modulating gene expression in acinar cells of pancreatitis associated protein
10/2008
10/30/2008WO2008130464A1 Macrocyclic ghrelin receptor modulators and methods of using the same
10/30/2008WO2008128455A1 Osteopontin functional epitopes, monoclonal antibodies against the epitopes and uses thereof
10/30/2008WO2008088583A3 Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
10/30/2008WO2008070049A8 Peptide and treatment for hiv-1 infection
10/30/2008WO2008057709A3 Sol-gel materials for cellular modulation
10/30/2008WO2008057208A3 Hcv ns3 protease inhibitors
10/30/2008WO2008019303A3 Pyridazinonyl macrocyclic hepatitis c serine protease inhibitors
10/30/2008WO2007076319A3 Human glp-1 mimetibodies and compositions for treating obesity and related disorders, methods and uses
10/30/2008US20080269143 Dual delta and mu opioid receptor antagonist; 3,6-Bis(Boc-Dmt-Tic-NH-methyl)-2(1H)-pyrazinone
10/30/2008US20080269142 Endogenous thiadiazabicyclo glutathione-adduct
10/30/2008US20080269141 Peptide Substance Restoring Myocardium Function
10/30/2008US20080269140 Conformationally Constrained Smac Mimetics and the Uses Thereof
10/30/2008US20080268474 Prion protein ligands and methods of use
10/30/2008US20080267917 N-functionalized amides as hepatitis c serine protease inhibitors
10/30/2008US20080267916 Cyclic p3 tripeptide hepatitis c serine protease inhibitors
10/30/2008US20080267882 Multimeric RGD (arginine-glycine-aspartic acid (Arg-Gly-Asp)) peptide; positron emission tomography; angiogenesis; kits
10/30/2008CA2685182A1 Osteopontin functional epitopes, monoclonal antibody against the epitopes and uses thereof
10/30/2008CA2677399A1 Macrocyclic ghrelin receptor modulators and methods of using the same
10/29/2008EP1984387A1 New polypeptides kxk and their use
10/29/2008EP1562979B1 Tubulysins, method for producing the same and tubulysin preparations
10/29/2008CN101296937A Asymmetric synthesis of peptides
10/29/2008CN100429225C Promyostatin peptides and methods of using same
10/29/2008CN100429223C Process for producing cyclo (D-phenylpropyl-D-group) dipeptide
10/28/2008US7442695 Depeptidized inhibitors of hepatitis C virus NS3 protease
10/28/2008CA2359027C S-nitrosothiols as agents for the treatment of circulatory dysfunctions
10/23/2008WO2008126783A1 Method for producing dipeptide
10/23/2008WO2008107362A3 Stabiliser and inhibitors of factor vii
10/23/2008WO2006121926A8 Neural regeneration peptides and methods for their use
10/23/2008US20080262200 Peptidomimetics; kits; macrocyclization
1 ... 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 ... 307